-
-
-
-
-
-
-
Halozyme (HALO) Announces Takeda (TAK) Receives FDA Approval for HYQVIA Co-formulated with ENHANZE as Maintenance Therapy in Adults with CIDP
-
-
-
-
-
-
-
Mirum Pharmaceuticals and Takeda Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan
-
-
15,434 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

